31
Non invasive Non invasive ventilation and ventilation and LV dysfunction LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Embed Size (px)

Citation preview

Page 1: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Non invasive Non invasive ventilation and LV ventilation and LV dysfunctiondysfunction

Fekri Abroug

ICU. CHU F.Bourguiba

Monastir. Tunisia

Page 2: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

How can cardiogenic pulmonary edema-inducedHow can cardiogenic pulmonary edema-induced

respiratory dysfunctionrespiratory dysfunction aggravate aggravate cardiac dysfunctioncardiac dysfunction

and circulatory failure ?and circulatory failure ?

Page 3: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Cardiogenic Pulmonary edemaCardiogenic Pulmonary edema

Hypoxemia Hypoxemia WOB WOB Exaggerated decrease Exaggerated decrease in pleural pressure in pleural pressure

at inspirationat inspiration

Page 4: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Cardiogenic Pulmonary edemaCardiogenic Pulmonary edema

Hypoxemia Hypoxemia WOB WOB

risks of risks of myocardial myocardial

ischemia ischemia

risks of risks of critical organs critical organs hypoperfusionhypoperfusion

Page 5: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Viires et a. Viires et a. J Clin InvestJ Clin Invest 1983 1983

Page 6: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Cardiogenic Pulmonary edemaCardiogenic Pulmonary edema

HypoxemiaHypoxemia WOBWOB Exaggerated decrease Exaggerated decrease in pleural pressure in pleural pressure

at inspirationat inspiration

Increase in LV afterload Increase in LV afterload

Page 7: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Cardiogenic Pulmonary edemaCardiogenic Pulmonary edema

HypoxemiaHypoxemia WOBWOB Exaggerated decrease Exaggerated decrease in pleural pressure in pleural pressure

at inspirationat inspiration

risks of risks of myocardial myocardial

ischemia ischemia

Increase in LV afterload Increase in LV afterload

risks of risks of decrease in decrease in

Stroke Volume Stroke Volume

Page 8: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Cardiogenic Pulmonary edemaCardiogenic Pulmonary edema

Hypoxemia Hypoxemia WOB WOB Exaggerated decrease Exaggerated decrease in pleural pressure in pleural pressure

at inspirationat inspiration

risks of risks of myocardial myocardial

ischemia ischemia

decrease decrease in CaOin CaO22

risks of risks of critical organs critical organs hypoperfusionhypoperfusion

Increase in LV afterloadIncrease in LV afterload

risks of risks of decrease in decrease in

Stroke Volume Stroke Volume

Risks of aggravation of cardiac dysfunction (vicious circle) Risks of aggravation of cardiac dysfunction (vicious circle)

and of circulatory failureand of circulatory failure

Page 9: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

How can positive pressure ventilation improve How can positive pressure ventilation improve

cardiac dysfunctioncardiac dysfunction and circulatory failure and circulatory failure

in patients with cardiogenic pulmonary edema?in patients with cardiogenic pulmonary edema?

Page 10: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Positive pressure ventilation in cardiogenic pulmonary edemaPositive pressure ventilation in cardiogenic pulmonary edema

Hypoxemia Hypoxemia WOB WOB Exaggerated decrease Exaggerated decrease in pleural pressure in pleural pressure

at inspirationat inspiration

risks of risks of myocardial myocardial

ischemia ischemia

decrease decrease in CaOin CaO22

risks of risks of critical organs critical organs hypoperfusionhypoperfusion

risks of risks of decrease in decrease in

Stroke Volume Stroke Volume

Postive pressure ventilation by breaking the vicious circle Postive pressure ventilation by breaking the vicious circle prevents aggravation of cardiac dysfunctionprevents aggravation of cardiac dysfunction

and of circulatory failureand of circulatory failure

Page 11: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

NIV and Cardiogenic NIV and Cardiogenic Pulmonary edema (CPE)Pulmonary edema (CPE) NIV: important tool in ARF

Reduces the need for invasive ventilation Reduces IMV complications Reduces ICU complications, stay, mortality

CPE common medical emergency NIV increases cardiac output Improves gaz exchange Decreases endotracheal intubation Trends towards decrease in mortality

Page 12: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Clinical goals in CPEClinical goals in CPE

Improve systemic oxygen saturation Reduction in LV preload Reduction in LV afterload

Oxygen through high flow facemask Morphine Diuretics nitrates

Page 13: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

CPAP is effective in CPE CPAP is effective in CPE unresponsive to medical Rxunresponsive to medical Rx

Poulton Lancet 1936Poulton Lancet 1936

Increase in inspiratory and expiratory flow and pressure Increases Vt Unloads inspiratory muscles Improves alveolar ventilation Reexpands flooded alveoli Counteracts intrinsic PEEP

Prevents micro-atelectasis Improves the P-V curve relation Increases in intrathoracic pressure reduces the

left ventricular preload and afterload Increases cardiac output in CHF

Page 14: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Both CPAP and bilevel non-Both CPAP and bilevel non-invasive ventilation proved invasive ventilation proved effective in treating CPEeffective in treating CPE

Better than conventional oxygen therapy

Page 15: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Resolution time: p=0.002

N=19N=18

Intubation rate: 5% vs 33% (p=0.037)

Page 16: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

130 patients attending the ED for CPE Randomized to

O2: n=65 NIPSV: n=65

Primary endpoint: need for intubation Secondary endpoints: mortality,

physiological variables

Page 17: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Intubation rate: 25% vs 20% (p=0.5)

Mortality: 14% vs 8% (p=0.4)

Subgroup analysis: no difference

P=0.01

Page 18: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia
Page 19: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

CPAP vs Conventional medical CPAP vs Conventional medical treatment: intubation ratestreatment: intubation rates

NNT=7

Page 20: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

CPAP vs Conventional medical CPAP vs Conventional medical treatment: death ratestreatment: death rates

NNT=8

Page 21: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

BiPAP vs Conventional medical BiPAP vs Conventional medical treatment: intubation ratestreatment: intubation rates

Page 22: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

BiPAP vs Conventional medical BiPAP vs Conventional medical treatment: death ratestreatment: death rates

Page 23: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

How does CPAP How does CPAP compare with Bi-compare with Bi-PAP?PAP?

Page 24: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

CPAP vs BiPAP: intubationCPAP vs BiPAP: intubation

Page 25: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

CPAP vs BiPAP: mortalityCPAP vs BiPAP: mortality

Page 26: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

36 patients with CPE and hypercapnia (in the ED)

Randomization to CPAP (n=18) or NIPSV (n=18)

Endpoints: Endotracheal intubation Death rate Resolution time (SpO2>96%, BR<30)

Page 27: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia
Page 28: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Role of NIV in CPE Role of NIV in CPE due to LV diastolic due to LV diastolic dysfunctiondysfunction

Page 29: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia
Page 30: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

In all types of CPE, CPAP improves oxygenation

In LV diastolic dysfunction, this occurs through a decrease of LV diastolic volume (preload) and in MAP

In LV systolic dysfunction, CPAP both decreases preload and increases LVEF

Page 31: Non invasive ventilation and LV dysfunction Fekri Abroug ICU. CHU F.Bourguiba Monastir. Tunisia

Greetings Greetings from from

MonastirMonastir